RTW Investments Buys $164M Stake in Tango Therapeutics as Stock Surges 840%
Tango Therapeutics (NASDAQ:TNGX) has surged by 840% over the past year, and RTW Investments disclosed a significant purchase of 11.8 million shares valued at $164.37 million on May 15, 2026. The fund increased its position in TNGX to about 3% of its reportable assets under management.
Topics: institutional investment RTW Investments SEC filing Tango Therapeutics